Bank of Montreal Can Boosts Stake in Humana Inc. (NYSE:HUM)

Bank of Montreal Can lifted its stake in Humana Inc. (NYSE:HUM) by 18.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 189,168 shares of the insurance provider’s stock after acquiring an additional 29,460 shares during the period. Bank of Montreal Can owned 0.16% of Humana worth $60,452,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Creative Financial Designs Inc. ADV raised its holdings in Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. boosted its stake in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares in the last quarter. Atwood & Palmer Inc. purchased a new position in Humana in the third quarter worth $29,000. Ashton Thomas Securities LLC acquired a new position in shares of Humana during the third quarter worth $31,000. Finally, Your Advocates Ltd. LLP lifted its holdings in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HUM has been the topic of several recent analyst reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 target price on shares of Humana in a research report on Tuesday, October 1st. Wells Fargo & Company decreased their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Royal Bank of Canada dropped their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Piper Sandler cut shares of Humana from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $392.00 to $274.00 in a report on Thursday, October 3rd. Finally, UBS Group dropped their price objective on shares of Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, October 4th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $315.86.

Humana Stock Performance

Shares of NYSE HUM opened at $296.83 on Thursday. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $526.47. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The company’s fifty day moving average price is $275.91 and its 200 day moving average price is $330.00. The company has a market capitalization of $35.74 billion, a PE ratio of 26.29, a price-to-earnings-growth ratio of 2.40 and a beta of 0.52.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. On average, research analysts predict that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.19%. Humana’s dividend payout ratio (DPR) is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.